• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX; LIMB STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX; LIMB STENT GRAFT Back to Search Results
Model Number I20-13/C70F SA
Device Problems Failure To Adhere Or Bond (1031); Leak/Splash (1354); Material Rupture (1546)
Patient Problems Failure of Implant (1924); Pain (1994); Rupture (2208)
Event Date 12/02/2017
Event Type  Injury  
Manufacturer Narrative
The device involved in the event will not be returned for evaluation as it remains implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
On (b)(6) 2014, the patient was initially implanted with a bifurcated stent, a suprarenal extension and a limb extension.On (b)(4) 2017 endologix was made aware a 1b endoleak.It was reported that the patient went to the hospital with abdominal pain.A type 1b endoleak from right common iliac with possible rupture was discovered.The physician elected to implant another limb stent extension to seal the leak.No evidence of endoleak was present on final angiogram.The patient was reported as stable.
 
Manufacturer Narrative
The manufacturing lot evaluation confirmed all devices met specifications prior to release.The device was not returned as the device remains implanted therefore no evaluation was completed.At the completion of the clinical assessment, clinical was only able to find substantial evidence to support the following reported event of a secondary endovascular procedure.Clinical was unable to find substantial evidence to support the following reported events of type ib endoleak of the right common iliac, a rupture and that the patient condition in stable due to the lack of medical information.Several attempts were made to retrieve the medical records and images.These requests were denied.The most likely cause of the distal loss of seal and possible rupture could not be determined due to the lack of medical information surrounding the initial implant procedure, rupture event and the reported secondary intervention.Reportedly, the patient was in stable condition post the secondary repair procedure.To date there has been no reports of further negative patient sequelae.Endologix continues to investigate this event and similar events to ensure the highest quality and patient safety.These types of events will be monitored and trended as part of the quality system.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
LIMB STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key7149381
MDR Text Key95870701
Report Number2031527-2017-00698
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 12/02/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/27/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2017
Device Model NumberI20-13/C70F SA
Device Lot Number1230491-011
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received12/02/2017
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BIFURCATED STENT GRAFT, LOT # 1252257048; VELA SUPRARENAL, LOT # 1264514028; BIFURCATED STENT GRAFT, LOT # 1252257048; VELA SUPRARENAL, LOT # 1264514028
Patient Outcome(s) Congenital Anomaly; Required Intervention;
Patient Age83 YR
-
-